Using data from the European Prevention of Alzheimer's Dementia (EPAD) cohort, the study found that APOE ε4 carriers who used HRT had improved delayed memory performance and larger brain volumes, specifically in the entorhinal cortex and amygdala, compared to non-users and non-carriers. Here, APOE is linked to Alzheimer disease.